Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

29 Oct 2007 14:28

Skyepharma PLC29 October 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES (1). Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached: Skyepharma PLC - GB0008123571 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: (Yes) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: (N/A) An event changing the breakdown of voting rights: (N/A) Other (please specify) : (N/A) 3. Full name of person(s) subject to the notification obligation: UBS INVESTMENT BANK 4. Full name of shareholder(s) (if different from 3.): UBS AG London Branch 5. Date of the transaction and date on which the threshold is crossed or reachedif different): 18th October 2007 6. Date on which issuer notified: 22nd October 2007 7. Threshold(s) that is/are crossed or reached: 5.46% 8. Notified details: A: Voting rights attached to shares Class/type of shares Situation previous to if possible using the the Triggering ISIN CODE transaction Number of shares Number of voting Rights GB0008123571 34,370,765 34,370,765 Resulting situation after the triggering transaction Class/type of shares Number of shares Number of voting rights % of voting rights if possible using the ISIN CODE Direct Indirect Direct Indirect Direct Indirect GB0008123571 26,439,644 44,473,360 - 5.46% B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Date Exercise/Conversion Number of voting % of voting financial Period/ Date rights that may be rights instrument acquired if the instrument is exercised/ converted. - - - - - Total (A+B)Number of voting rights % of voting rights 44,473,360 5.46% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: UBS AG London Branch - 44,473,360 - 5.46% Proxy Voting: 10. Name of the proxy holder: - 11. Number of voting rights proxy holder will cease to hold: - 12. Date on which proxy holder will cease to hold voting rights: - 13. Additional information: - 14. Contact name: Cintia GoertzDirector UBS AG 15. Contact telephone number: 0207 567 6116 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
12th May 201610:04 amBUSForm 8.3 - Skyepharma Plc
12th May 20169:51 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
11th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
11th May 20169:46 amBUSForm 8.3 - Skyepharma Plc
11th May 20169:16 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
10th May 20162:29 pmRNSForm 8.3 - Skyepharma PLC
10th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
10th May 201611:04 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
10th May 201610:10 amBUSForm 8.3 - Skyepharma Plc
10th May 20169:59 amRNSForm 8.3 - Skyepharma
10th May 20169:52 amRNSForm 8.3 -Vectura Group plc
10th May 20169:35 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
10th May 20169:27 amRNSForm 8 (DD) - Peter Grant
10th May 20169:25 amRNSForm 8 (DD) - Andrew Derodra
9th May 20161:46 pmRNSForm 8.3 - Skyepharma Plc
9th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
9th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
9th May 201610:58 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
9th May 201610:22 amBUSForm 8.3 - Skyepharma Plc
6th May 20164:22 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc amendment
6th May 201612:00 pmRNSForm 8.5 (EPT/RI) -Vectura Group PLC
6th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
6th May 201610:59 amRNSDirector/PDMR Shareholding
5th May 20163:08 pmRNSNotice of Results
5th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
5th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
5th May 201611:26 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
5th May 201611:03 amRNSForm 8.3 - SkyePharma plc
5th May 20169:50 amBUSForm 8.3 - Skyepharma Plc
4th May 20163:29 pmRNSForm 8.3 - Skyepharma PLC
4th May 20162:05 pmRNSForm 8.3 - Skyepharma Plc
4th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
4th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
4th May 201611:16 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
4th May 201611:13 amPRNForm 8.3 - Skyepharma Plc
4th May 201610:52 amRNSForm 8.3 - Skyepharma PLC
4th May 20169:45 amBUSForm 8.3 - Skyepharma Plc
3rd May 20163:26 pmRNSForm 8.3 - Skyepharma plc
3rd May 201612:03 pmRNSForm 8.3 - Skyepharma PLC
3rd May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
3rd May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
3rd May 201611:59 amPRNForm 8.3 - Skyepharma Plc
3rd May 201611:17 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
3rd May 201610:38 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
29th Apr 20163:21 pmRNSForm 8.3 - Skyepharma PLC
29th Apr 20162:47 pmRNSForm 8.3 - Skyepharma
29th Apr 20162:07 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC REPLACEMENT
29th Apr 20162:00 pmRNSForm 8.3 - Skyepharma PLC
29th Apr 20161:04 pmRNSForm 8.3 - Vectura Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.